Breaking Business News | Breaking business news AM | Breaking Business News PM

Chloroquine Use For COVID-19 Coronavirus Shows No Benefit In First Small—But Limited—Controlled Trial

25 Mar 2020

The study’s small size and other weaknesses mean it does not offer a lot of helpful information in determining the possible utility of hydroxychloroquine, according to experts who reviewed the study.

Read the full article here.
This content was originally published by Forbes Magazine. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Forbes Magazine

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.